Update on melanoma epigenetics

Current Opinion in Oncology

Volumn 27, Issue 5, 2015, Pages 420-426

  De Unamuno, Blanca ^a   Palanca, Sarai ^a   Botella, Rafael ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Histone modification; Melanoma; Methylation; Noncoding RNA

Indexed keywords

DNA; HISTONE; LONG UNTRANSLATED RNA; MICRORNA; UNTRANSLATED RNA;

APOPTOSIS; CANCER GENETICS; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN STRUCTURE; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HISTONE MODIFICATION; HUMAN; MELANOMA; MELANOMA CELL; METHYLATION; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; REVIEW; CELL SURVIVAL; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; IMMUNOTHERAPY; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROGNOSIS; SKIN TUMOR; TRENDS;

CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; IMMUNOTHERAPY; MELANOMA; MICRORNAS; MOLECULAR TARGETED THERAPY; PROGNOSIS; SKIN NEOPLASMS;

EID: 84942589593     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0000000000000217     Document Type: Review

References (73)

1. Schultz J, Lorenz P, Gross G, et al. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorageindependent growth. Cell Res 2008; 18:549-557.
2. Chen J, Feilotter HE, Pare GC, et al. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 2010; 176:2520-2529.
3. Georgantas RW, Streicher K, Luo X, et al. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D. Pigment Cell Melanoma Res 2014; 27:275-286. This study demonstrated hsa-miR-206 is im plicated in cell growth and migration/invasion and identifies its targets.
4. Felicetti F, Errico MC, Bottero L, et al. The promyelocytic leukemia zinc fingermicroRNA-221/-222 pathway controls melanoma progression th rough multiple oncogenic mechanisms. Cancer Res 2008; 68:2745-2754.
5. Igoucheva O, Alexeev V. MicroRNA-dependent regulation of cKit in cutaneous melanoma. Biochem Biophys Res Commun 2009; 379:790-794.
6. Dar AA, Majid S, de Semir D, et al. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem 2011; 286:16606-16614.
7. Li JR, Wang JQ, Gong Q, et al. MicroRNA-328 inhibits proliferation of human melanoma cells by targeting TGFb2. Asian Pac J Cancer Prev 2015; 16:1575-1579. In this study, it is demonstrated that miR-328 is impl icated in proliferation and its levels are decreased in melanoma cells lines.
8. Luo C, Tetteh PW, Merz PR, et al. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target g enes. J Invest Dermatol 2013; 133:768-775.
9. Martin Del Campo SE, Latchana N, Levine KM, et al. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of miR-21 inhibitor. PLoS One 2015; 10:e0115919.
10. Yang CH, Pfeffer SR, Sims M, et al. The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis. J Biol Chem 2015; 290:6037-6046.
11. Boyle GM, Woods SL, Bonazzi VF, et al. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res 2011; 24:525-537.
12. Gaziel-Sovran A, Segura MF, Di Micco R, et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 2011; 20:104-118.
13. He inemann A, Zhao F, Pechlivanis S, et al. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res 2012; 72:460-471.
14. Noman MZ, Buart S, Romero P, et al. Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res 2012; 72:4629-4641.
15. Mazar J, DeBlasio D, Govindarajan SS, et al. Epigenetic regulation of micro-RNA-375 and its role in melanoma development in humans. FEBS Lett 2011; 585:2467-2476.
16. Mazar J, Khaitan D, DeBlasio D, et al. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma. PLoS One 2011; 6:e24922.
17. Leibowitz-Amit R, Sidi Y, Av ni D. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma. Pigment Cell Melanoma Res 2012; 25:740-757.
18. Kanemaru H, Fukushima S, Yamashita J, et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 2011; 61:187-193.
19. Fleming NH, Zhong J, da Silva IP, et al. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer 2015; 121:51-59.
20. Stark MS, Bonazzi VF, Boyle GM, et al. MiR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma. Oncotarget 2015. [Epub ahead of print]
21. Reuland SN, Smith SM, Bemis LT, et al. MicroRNA-26a is strongly downregulated in melanoma and ind uces cell death through repression of silencer of death domains (SODD). J Invest Dermatol 2013; 133:1286-1293.
22. Seftor RE, Seftor EA, Gehlsen KR, et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A 1992; 89:1557-1561.
23. Jiang L, Lv X, Li J, et al. The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma. Acta Histochem 2012; 114:582-588.
24. Satzger I, Mattern A, Kuettler U, et al. microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells. Exp Dermatol 2012; 21:509-514.
25. Liu S, Kumar SM, Lu H, et al. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-kB1-Snail1 pathway in melanoma. J Pathol 2012; 226:61-72.
26. Chen J, Feilotter HE, Pare GC, et al. MicroRNA 193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 2010; 176:2520-2529.
27. Noguchi S, Mori T, Hoshino Y, et al. Comparative study of antioncogenic microRNA-145 in canine and human malignant melanoma. J Vet Med Sci 2012; 74:1-8.
28. Noguchi S, Mori T, Otsuka Y. Antioncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J Biol Chem 2012; 287:11769-11777.
29. Levati L, Pagani E, Romani S, et al. MicroRNA-155 targets the SKI gene in human melanoma cell lines. Pigment Cell Melanoma Res 2011; 24:538-550.
30. Greenberg E,Hershkovitz L,Itzhaki O,et al. Regulation of cancer aggressive features in melanoma cells by microRNAs PLoS One 2011 6, e18936.
31. Satzger I, Mattern A, Kuettler U, et al. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumour cell proliferation and apoptosis in malignant melanoma. Int J Cancer 2010; 126: 2553-2562.
32. Friedman EB, Shang S, de Miera EV, et al. Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med 2012; 10:155.
33. Felli N, Felicetti F, Lustri AM, et al. miR-126&126restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One 2013; 8:e56824.
34. Dar AA, Majid S, Rittsteuer C, et al. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst 2013; 105:433-442.
35. Jin L, Hu WL, Jiang CC, et al. MicroRNA-149, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci U S A 2011; 108:15840-15845.
36. Muller DW, Bosserhoff AK. Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene 2008; 27:6698-6706.
37. Lodygin D, Tarasov V, Epanchintsev A, et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008; 7:2591-2600.
38. Mazar J, DeYoung K, Khaitan D, et al. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One 2010; 5:e13779.
39. Bell RE, Khaled M, Netanely D, et al. Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1. J Invest Dermatol 2014; 134:441-451.
40. Levy C, Khaled M, Iliopoulos D, et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 2010; 40:841-849.
41. Penna E, Orso F, Cimino D, et al. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 2011; 30:1990-2007.
42. Elson-Schwab I, Lorentzen A, Marshall CJ. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One 2010; 5:e13176.
43. Dynoodt P, Speeckaert R, De Wever O, et al. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells. Int J Oncol 2013; 42:1443-1451.
44. Segura MF, Hanniford D, Menendez S, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmiaassociated transcription factor. Proc Natl Acad Sci U S A 2009; 106:1814-1819.
45. Mueller DW, Bosserhoff AK. MicroRNA miR-196a controls melanoma-Associated genes by regulating HOX-C8 expression. Int J Cancer 2011; 129:1064-1074.
46. Braig S, Mueller DW, Rothhammer T, Bosserhoff AK. MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci 2010; 67:3535-3548.
47. Tian Y,Zhang X,Hao Y,et al. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma Melanoma Res 2014 24 335-341.
48. Tang L, Zhang W, Su B, Yu B. Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic po tential of metastatic melanoma. Biomed Res Int 2013;2013:251098.
49. Flockhart RJ, Webster DE, Qu K, et al. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res 2012; 22:1382. 50.
50. Li R, Zhang L, Jia L, et al. Long noncoding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation. PLoS One 2014; 9:e100893.
51. Khaitan D, Dinger ME, Mazar J, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res 2011; 71:3852-3862.
52. Mazar J, Zhao W, Khalil AM, et al. The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells. Oncotarget 2014; 5:8959-8969.
53. Wu CF, Tan GH, Ma CC, Li L. The noncoding RNA llme23 drives the malignant property of human melanoma cells. J Genet Genomics 2013; 40:179-188.
54. Pasmant E,Laurendeau I,Héron D, et al Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumour family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 2007 67 3963-3969.
55. Sigalotti L, Covre A, Fratta E, et al. Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. J Transl Med 2010; 8:56.
56. Tiffen J, Gallagher SJ, Hersey P. EZH2: an emerging role in melanoma biology and strategies for targeted therapy. Pigment Cell Melanoma Res 2015; 28:21-30.
57. McHugh JB, Fulle n DR, Ma L, et al. Expression of polycomb group protein EZH2 in nevi and melanoma. J Cutan Pathol 2007; 34:597-600.
58. Kampilafkos P, Melachrinou M, Kefalopoulou Z, et al. Epige netic modifications in cutaneous malignant melanoma: EZH2, H3K4me2, and H3K27me3 immunohistochemical expression is enhanced at the invasion front of the tumor. Am J Dermatopathol 2015; 37:138-144.
59. Bachmann I M, Halvorsen OJ, Collett K, et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 2006; 24:268-273.
60. Fan T, Jiang S, Chung N, et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res 2011; 9:4 18-429.
61. Ceol CJ, Houvras Y, Jane-Valbuena J, et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 2011; 471:513-517.
62. Kostaki M, Manona AD, Stavraka I, et al. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1expression in sporadic cutaneous melanoma. Exp Dermatol 2014; 23:332-338.
63. Tanemura A, Terando AM, Sim MS, et al. CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 2009; 15:1801-1807.
64. Hoon DS, Spugnardi M, Kuo C, et al. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 2004; 23:4014-4022.
65. Tellez CS , Shen L, Esté cio MR, et al. CpG island methylation profiling in human melanoma cell lines. Melanoma Res 2009; 19:146-155.
66. Liu S, Ren S, Howell P, et al. Identification of novel ep igenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res 2008; 21:545-558.
67. Conway K, Edmiston SN, Khondker ZS, et al. DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res 2011; 24:352-360.
68. Thomas NE, Slater NA, Edmiston SN, et al. DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. Pigment Cell Melanoma Res 2014; 27:1097-1105.
69. Sigalotti L, Covre A, Fr atta E, et al. Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. J Transl Med 2012; 10:185.
70. Sigalotti L, Fratta E, Bidoli E, et al. Methylation levels of the ' 'long interspersed nucleotide element-1'' repetitive sequences predict survival of melanoma patients. J Transl Med 2011; 9:78.
71. Mori T, O'Day SJ, Umetani N, et al. Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. J Clin Oncol 2005; 23:9351-9358.
72. Tuominen R, Jewell R, van den Oord JJ, et al. MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma. Int J Cancer 2015; 136:2844-2853.
73. Lian CG, Xu Y, Ceol C , et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012; 150:1135-1146.